top of page
BPIQ Blog
Aug 19, 20221 min read
Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Aug 19, 20221 min read
Free Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Aug 9, 20221 min read
Biopharma Daily Pulse - 08/09/22
$XBI $90.75 | -3.34% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 9, 20221 min read
Free Biopharma Daily Pulse - 08/09/22
$XBI $90.75 | -3.34% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 9, 20221 min read
Biopharma Mid Morning Pulse - 08/09/22
(Posted 10:07am CST) $XBI $91.00 | -3.08% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Aug 9, 20221 min read
Free Biopharma Mid Morning Pulse - 08/09/22
(Posted 10:07am CST) $XBI $91.00 | -3.08% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jun 10, 20223 min read
Biopharma Pulse - 6/6-6/10 Week in Review
As we begin June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for...
Jun 9, 20221 min read
Biopharma Daily Stock Updates - 06/09/22
$XBI $70.26 | -4.03% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates Pipeline Updates #OLMA +8.5%...
Jun 9, 20221 min read
Free Biopharma Daily Stock Updates - 06/09/22
$XBI $70.26 | -4.03% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates Pipeline Updates #OLMA +8.5%...
Jun 22, 20214 min read
COVID-19 Therapeutic Stocks to Watch (June 2021)
Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page